Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells.
about
Homeostatic modulation of cell surface KDR and Flt1 expression and expression of the vascular endothelial cell growth factor (VEGF) receptor mRNAs by VEGFVascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasisInteraction between hex and GATA transcription factors in vascular endothelial cells inhibits flk-1/KDR-mediated vascular endothelial growth factor signalingNucleolar localization of human methionyl-tRNA synthetase and its role in ribosomal RNA synthesisSemaphorin SEMA3F localization in malignant human lung and cell lines: A suggested role in cell adhesion and cell migrationThe Potential Role of Kallistatin in the Development of Abdominal Aortic AneurysmVitreous mediators in retinal hypoxic diseasesVEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic formsEtk/Bmx transactivates vascular endothelial growth factor 2 and recruits phosphatidylinositol 3-kinase to mediate the tumor necrosis factor-induced angiogenic pathwayNeuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesisVascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinaseCharacterization of the neuropilin-1 promoter; gene expression is mediated by the transcription factor Sp1.Vascular endothelial growth factor KDR receptor signaling potentiates tumor necrosis factor-induced tissue factor expression in endothelial cells.TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotypePlasmodium chabaudi-infected erythrocytes adhere to CD36 and bind to microvascular endothelial cells in an organ-specific wayEffect of inflammatory cytokines on the expression of the vascular endothelial growth factor-C.Golimumab as rescue therapy for refractory immune-mediated uveitis: a three-center experience.Induced migration of endothelial cells into 3D scaffolds by chemoattractants secreted by pro-inflammatory macrophages in situ.Vascular endothelial growth factor receptor-2 in breast cancer.Lymphangiogenesis and lymphatic metastasis in breast cancer.Leptin regulation of proangiogenic molecules in benign and cancerous endometrial cells.Sp1 and krüppel-like factor family of transcription factors in cell growth regulation and cancer.Angiogenesis in head and neck squamous cell carcinoma.Hyperoxia causes regression of vitreous neovascularization by downregulating VEGF/VEGFR2 pathway.Pathophysiology of lung injury induced by common bile duct ligation in mice.TNF-alpha is critical for ischemia-induced leukostasis, but not retinal neovascularization nor VEGF-induced leakageAdalimumab specifically induces CD3(+) CD4(+) CD25(high) Foxp3(+) CD127(-) T-regulatory cells and decreases vascular endothelial growth factor plasma levels in refractory immuno-mediated uveitis: a non-randomized pilot intervention studyThe role of growth factors in the pathogenesis of diabetic retinopathy.Hericium erinaceus Inhibits TNF-α-Induced Angiogenesis and ROS Generation through Suppression of MMP-9/NF-κB Signaling and Activation of Nrf2-Mediated Antioxidant Genes in Human EA.hy926 Endothelial Cells.Matrix metalloproteinase-1-mediated up-regulation of vascular endothelial growth factor-2 in endothelial cells.Induction of neuropilin-1 and vascular endothelial growth factor by epidermal growth factor in human gastric cancer cellsPathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues.Angiostatin overexpression is associated with an improvement in chronic kidney injury by an anti-inflammatory mechanism.A Possible Role for TNF-α in Coordinating Inflammation and Angiogenesis in Chronic Liver Disease and Hepatocellular Carcinoma.Soluble and membranous vascular endothelial growth factor receptor-2 in pregnancies complicated by pre-eclampsiaBAFF and APRIL as TNF superfamily molecules and angiogenesis parallel progression of human multiple myeloma.Venom from Cuban Blue Scorpion has tumor activating effect in hepatocellular carcinoma.Investigational VEGF antagonists for psoriasis.Key Features of the Intragraft Microenvironment that Determine Long-Term Survival Following TransplantationNeuropilins: a new target for cancer therapy.
P2860
Q22253478-D6921ADF-CF1A-4A42-A55C-C44BC7EEED45Q22305863-5C9021E5-5FDE-42AB-B579-AD861B8AD6D3Q24316239-9A2DB13C-7109-4C53-9A9A-89F655926C07Q24669732-BDF8A834-93E3-4385-817F-DE4FE3219A38Q24681536-02235643-1550-4A83-9242-02FB515622F5Q26741231-9850E596-1BE3-49E5-A406-551D9E5D1134Q27028225-77EA332A-0496-447F-AA43-D549245A5865Q28141270-B5DCEBB0-276B-47CB-9E00-FCEED698D1B3Q28207963-5B9247D3-92B1-4131-A8F8-ECC44F459B37Q28263245-9625AE97-C6D9-4F18-B63C-5BD8A9EEEA97Q28646403-C2E4753C-55E4-4613-9C4A-767523690467Q31131003-34D1563F-E1A0-4C5C-815F-3AA7D22C0749Q31518636-6004CE47-3895-4EAD-8104-DE56C55EC965Q33323527-BDD09845-03F6-4367-A8D7-5FF3B353E8BAQ33597754-033BA068-9F29-4CFC-8E3D-FDE9B423B57AQ33723780-1A7C476F-3CED-4B69-B4AB-C2826DAD9C96Q33757440-A55A33C8-FDF6-4679-BA9E-BF9AFDA618E5Q33762899-D71C2C76-AAD7-4683-BF6A-89C83AF4FBBFQ33912620-39D1807A-6B4E-426D-A92F-FCFC393B9428Q33940058-32FA167E-F742-4EBF-997B-0AA2FF1301A3Q33941240-1DC0E310-EBFF-4819-8A85-66D41DB253A7Q33952921-70A6CF1C-B98F-4B60-B973-5CDE85AA6EEAQ34004670-F3D3DBC1-589C-43D8-9D5D-9EF239034E26Q34544365-63EA630F-12D4-4A02-8694-0897198AE389Q35147819-61450679-1615-4FE8-813C-26F566C2C57FQ35642213-A645A074-765D-4F69-89B3-606653591EC2Q35820405-B577A37D-4197-4213-BA91-B2E9755BBA26Q35906962-BCDFB347-BC7C-46C6-826C-F088C95CE14EQ36448506-E9F57552-DD5E-4DA5-8307-A8E7050D1392Q36508733-C58261F7-F636-4B35-88BD-F29D96B19B60Q36646637-C3D24F34-310D-47D6-8D11-602680E62E82Q36803301-1F77B862-032F-4CB6-8C10-EE378F450618Q37086112-532825F4-51ED-4524-A134-91180BE869F3Q37197025-8596C456-79A7-4F20-AE0B-10582A209BF3Q37400965-93DF2CA2-66C9-4E4D-B5EF-16F24B41A88FQ37622417-C5B72E95-54E8-4DEB-A212-3E0D76D82BA5Q37712961-8B5A7E1F-B142-40C4-873A-A57F87E358E1Q37956733-A6FE1C62-72FD-4A88-AA76-9F4CF573FC19Q38008362-784D57EC-2B5A-4270-B3E5-C60D0FA717C8Q38161356-3C1FF4F2-274C-4F20-A181-B3DCD5BC61F3
P2860
Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Tumor necrosis factor-alpha re ...... an vascular endothelial cells.
@en
Tumor necrosis factor-alpha re ...... an vascular endothelial cells.
@nl
type
label
Tumor necrosis factor-alpha re ...... an vascular endothelial cells.
@en
Tumor necrosis factor-alpha re ...... an vascular endothelial cells.
@nl
prefLabel
Tumor necrosis factor-alpha re ...... an vascular endothelial cells.
@en
Tumor necrosis factor-alpha re ...... an vascular endothelial cells.
@nl
P2093
P50
P356
P1476
Tumor necrosis factor-alpha re ...... man vascular endothelial cells
@en
P2093
P304
22128-22135
P356
10.1074/JBC.273.34.22128
P407
P577
1998-08-01T00:00:00Z